Canada Life’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,538
| Closed | -$42K | – | 2244 |
|
|
2023
Q2 | $42K | Sell |
1,538
-424
| -22% | -$18.3K | ﹤0.01% | 2021 |
|
|
2023
Q1 | $114K | Buy |
1,962
+1,761
| +876% | +$86.9K | ﹤0.01% | 1966 |
|
|
2022
Q4 | $10K | Sell |
201
-989
| -83% | -$68.6K | ﹤0.01% | 2322 |
|
|
2022
Q3 | $97K | Buy |
1,190
+989
| +492% | +$73.9K | ﹤0.01% | 1991 |
|
|
2022
Q2 | $14K | Hold |
201
| – | – | ﹤0.01% | 2327 |
|
|
2022
Q1 | $24K | Hold |
201
| – | – | ﹤0.01% | 2321 |
|
|
2021
Q4 | $19K | Hold |
201
| – | – | ﹤0.01% | 2385 |
|
|
2021
Q3 | $18K | Hold |
201
| – | – | ﹤0.01% | 2451 |
|
|
2021
Q2 | $31K | Hold |
201
| – | – | ﹤0.01% | 2398 |
|
|
2021
Q1 | $32K | Hold |
201
| – | – | ﹤0.01% | 2426 |
|
|
2020
Q4 | $47K | Hold |
201
| – | – | ﹤0.01% | 2300 |
|
|
2020
Q3 | $44K | Hold |
201
| – | – | ﹤0.01% | 2211 |
|
|
2020
Q2 | $57K | Hold |
201
| – | – | ﹤0.01% | 2188 |
|
|
2020
Q1 | $58K | Hold |
201
| – | – | ﹤0.01% | 2086 |
|
|
2019
Q4 | $57K | Buy |
+201
| New | +$43.6K | ﹤0.01% | 2220 |
|
|
2019
Q3 | – | Sell |
-379
| Closed | -$34K | – | 1724 |
|
|
2019
Q2 | $34K | Hold |
379
| – | – | ﹤0.01% | 2521 |
|
|
2019
Q1 | $33K | Hold |
379
| – | – | ﹤0.01% | 2319 |
|
|
2018
Q4 | $51K | Hold |
379
| – | – | ﹤0.01% | 2366 |
|
|
2018
Q3 | $97K | Hold |
379
| – | – | ﹤0.01% | 2201 |
|
|
2018
Q2 | $97K | Buy |
379
+268
| +241% | +$66.3K | ﹤0.01% | 2190 |
|
|
2018
Q1 | $22K | Hold |
111
| – | – | ﹤0.01% | 2498 |
|
|
2017
Q4 | $16K | Hold |
111
| – | – | ﹤0.01% | 2511 |
|
|
2017
Q3 | $18K | Hold |
111
| – | – | ﹤0.01% | 2499 |
|
|
2017
Q2 | $15K | Hold |
111
| – | – | ﹤0.01% | 2518 |
|
|
2017
Q1 | $21K | Hold |
111
| – | – | ﹤0.01% | 2452 |
|
|
2016
Q4 | $16K | Hold |
111
| – | – | ﹤0.01% | 2507 |
|
|
2016
Q3 | $16K | Hold |
111
| – | – | ﹤0.01% | 2476 |
|
|
2016
Q2 | $11K | Hold |
111
| – | – | ﹤0.01% | 2495 |
|
|
2016
Q1 | $15K | Hold |
111
| – | – | ﹤0.01% | 2377 |
|
|
2015
Q4 | $22K | Hold |
111
| – | – | ﹤0.01% | 2350 |
|
|
2015
Q3 | $18K | Hold |
111
| – | – | ﹤0.01% | 2331 |
|
|
2015
Q2 | $45K | Hold |
111
| – | – | ﹤0.01% | 2265 |
|
|
2015
Q1 | $51K | Hold |
111
| – | – | ﹤0.01% | 2113 |
|
|
2014
Q4 | $62K | Buy |
+111
| New | +$63.1K | ﹤0.01% | 2005 |
|
Other funds holding KPTI
APM
PAI
Canada Life's KPTI Position: Q3 2023 in Review
Canada Life sold out of Karyopharm Therapeutics (KPTI) in Q3 2023, closing a stake of 1,538 shares — an estimated $42K sold.
Canada Life first reported a position in KPTI in Q4 2014 and held it in 34 quarters. The position peaked at $114K in Q1 2023. 118 funds tracked by Wall St. Rank hold KPTI as of Q3 2023.
- Canada Life reported no remaining Karyopharm Therapeutics position as of Q3 2023 after selling out during the quarter.
- Canada Life sold 1,538 Karyopharm Therapeutics shares in Q3 2023, an estimated $42K.
- Canada Life first reported a position in Karyopharm Therapeutics in Q4 2014 and held it in 34 quarters.
- Canada Life's Karyopharm Therapeutics position peaked at $114K in Q1 2023.
- 118 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2023.
Based on Canada Life's 13F filing for Q3 2023, filed 14 Nov 2023.